Next Article in Journal
Cumulative Epigenetic Abnormalities in Host Genes with Viral and Microbial Infection during Initiation and Progression of Malignant Lymphoma/Leukemia
Next Article in Special Issue
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
Previous Article in Journal
From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis
Previous Article in Special Issue
Parathyroid Hormone-Related Protein (PTHrP): A Key Regulator of Life/Death Decisions by Tumor Cells with Potential Clinical Applications
Open AccessReview

Protein Kinase C: An Attractive Target for Cancer Therapy

G. Gaslini Institute, L.go G. Gaslini 5, 16147, Genoa, Italy
Department of Experimental Medicine, General Pathology Section, University of Genoa, Via L.B. Alberti 2, 16132, Genoa, Italy
Author to whom correspondence should be addressed.
Cancers 2011, 3(1), 531-567;
Received: 23 December 2010 / Revised: 19 January 2011 / Accepted: 26 January 2011 / Published: 1 February 2011
(This article belongs to the Special Issue Cell Death and Cancer)
Apoptosis plays an important role during all stages of carcinogenesis and the development of chemoresistance in tumor cells may be due to their selective defects in the intracellular signaling proteins, central to apoptotic pathways. Consequently, many studies have focused on rendering the chemotherapy more effective in order to prevent chemoresistance and pre-clinical and clinical data has suggested that protein kinase C (PKC) may represent an attractive target for cancer therapy. Therefore, a complete understanding of how PKC regulates apoptosis and chemoresistance may lead to obtaining a PKC-based therapy that is able to reduce drug dosages and to prevent the development of chemoresistance. View Full-Text
Keywords: apoptosis; PKC; cancer; chemoresistance apoptosis; PKC; cancer; chemoresistance
Show Figures

Graphical abstract

MDPI and ACS Style

Marengo, B.; De Ciucis, C.; Ricciarelli, R.; Pronzato, M.A.; Marinari, U.M.; Domenicotti, C. Protein Kinase C: An Attractive Target for Cancer Therapy. Cancers 2011, 3, 531-567.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop